NEW YORK (GenomeWeb News) — German 3D protein structure-analysis company Proteros Biostructures this week said that an existing “silent partner” has invested an additional €1 million ($1.3 million) in the company.
 
Proteros, located in Martinsried, also said that the cash from Munich-based BayBG has “permitted” the company to acquire an additional €4.2 million in financing and research funds. Proteros did not disclose the source of this additional funding.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The president of France's National Research Agency has resigned, according to Nature News.

A senator wants a "right-to-try" provision in the US Food and Drug Administration funding bill, but an ethicist says at Stat News that it would undermine the role of clinical trials.

In PNAS this week: red algae Porphyra umbicalis genome, deep neural network model for sequencing peptides, and more.

The Guardian's Barbara Ellen has tried out some DNA testing services to see whether they provide valuable information.